Zeng, X., Zhang, H., Oh, A., Zhang, Y., & Yee, D. (2011). Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor. Breast Cancer Res Treat.
Chicago Style CitationZeng, Xianke, Hua Zhang, Annabell Oh, Yan Zhang, i Douglas Yee. "Enhancement of Doxorubicin Cytotoxicity of Human Cancer Cells By Tyrosine Kinase Inhibition of Insulin Receptor and Type I IGF Receptor." Breast Cancer Res Treat 2011.
Cita MLAZeng, Xianke, et al. "Enhancement of Doxorubicin Cytotoxicity of Human Cancer Cells By Tyrosine Kinase Inhibition of Insulin Receptor and Type I IGF Receptor." Breast Cancer Res Treat 2011.
Atenció: Aquestes cites poden no estar 100% correctes.